Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
DT-MiNi
Presence of Microplastics and Nanoplastics in Neurosurgery Patients
1 other identifier
observational
500
1 country
1
Brief Summary
Plastic particles are a ubiquitous pollutant in the living environment and food chain, so far, plenty of studies have reported the internal exposure of microplastics and nanoplastics in human tissues and enclosed body fluids. Neurosurgery is the only department that can open the skull. In addition to blood and cerebrospinal fluid, there are brain tissue and tumors in the presence of lesions. Whether any of these microplastics and nanoplastics are present remains a mystery. This prospective observational study will harvest biological samples of neurosurgery patients. The objective of this research is to be able to detect microplastics and nanoplastics on blood and operation samples of neurosurgery patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2023
CompletedFirst Posted
Study publicly available on registry
August 1, 2023
CompletedStudy Start
First participant enrolled
September 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJanuary 23, 2025
January 1, 2025
2.3 years
July 6, 2023
January 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
microplastics
Detection of microplastics in human brain tissue and the blood undergoing neurosurgery
baseline, intraoperative
nanoplastics
Detection of nanoplastics in human brain tissue and the blood undergoing neurosurgery
baseline, intraoperative
Interventions
biological samples analysis
Eligibility Criteria
Included patients age 18-80 years with any types of neurosurgery Excluded patients refuse to participate
You may qualify if:
- Age 18-80 years
- Any type of neurosurgery
You may not qualify if:
- ·refusal of the patient to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100070, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Runting Li, MD
Beijing Tiantan Hospital
- PRINCIPAL INVESTIGATOR
Yitong Jia, MD
Beijing Tiantan Hospital
- PRINCIPAL INVESTIGATOR
Ke Wang, MD
Beijing Tiantan Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
July 6, 2023
First Posted
August 1, 2023
Study Start
September 25, 2023
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
January 23, 2025
Record last verified: 2025-01